ILIAS Biologics ILIAS Therapeutics

(주)셀렉스라이프사이언스

News

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

[ENG] 보도자료

ILIAS Biologics, Inc. and UTMB report placenta-passing bilateral trafficking of exosomes in pregnant mouse model

페이지 정보

  • 작성자 : ILIAS Biologics
  • 작성일 : 19-07-18 14:04
  • 조회 : 142회

본문

 

Exosomes carry cellular signals, and traffic between fetal and maternal tissues to produce functional changes in recipient cells. In this study, we report feto-maternal and maternalfetal trafficking of exosomes indicative of paracrine signaling during pregnancy. Trafficking of exosomes suggests their potential role in pregnancy as biomarkers of fetal functions and usefulness as a carrier of drugs and other cargo to the fetal side during pregnancy.

 

Article in Press : https://www.ajog.org/article/S0002-9378(19)30774-4/abstract

 

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기